Review



interactive, multimedia touchscreen computer  (Greiner Bio)


Bioz Verified Symbol Greiner Bio is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Greiner Bio interactive, multimedia touchscreen computer
    Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)
    Interactive, Multimedia Touchscreen Computer, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/interactive, multimedia touchscreen computer/product/Greiner Bio
    Average 90 stars, based on 1 article reviews
    interactive, multimedia touchscreen computer - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: a systematic review"

    Article Title: Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: a systematic review

    Journal: European Journal of Cancer Prevention

    doi: 10.1097/CEJ.0000000000000796

    Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)
    Figure Legend Snippet: Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)

    Techniques Used: Control, Clarification Assay, Biomarker Discovery



    Similar Products

    interactive, multimedia touchscreen computer  (Greiner Bio)
    90
    Greiner Bio interactive, multimedia touchscreen computer
    Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)
    Interactive, Multimedia Touchscreen Computer, supplied by Greiner Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/interactive, multimedia touchscreen computer/product/Greiner Bio
    Average 90 stars, based on 1 article reviews
    interactive, multimedia touchscreen computer - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)

    Journal: European Journal of Cancer Prevention

    Article Title: Interactive or tailored digital interventions to increase uptake in cervical, breast, and colorectal cancer screening to reduce health inequity: a systematic review

    doi: 10.1097/CEJ.0000000000000796

    Figure Lengend Snippet: Colorectal cancer screening: study characteristics and results of colorectal cancer screening including colonoscopy and fecal occult blood test/fecal immunochemical test ( n = 10)

    Article Snippet: Greiner et al . (2014 ), USA , 42% non-Hispanic African American, 28% non-Hispanic white, 27% Hispanic Intervention group: n = 234 Control group: n = 236 Age 45–70 , Info and education on CRC screening. Participants responded to ‘implementations intentions’ planning questions specific to CRC screening. Interactive, multimedia touchscreen computer that used either English or Spanish text with narration through headphones, as well as pictures and video targeted to the race/ ethnicity of the participant. , Self-reported CRC screening Follow-up: 26 weeks Intervention group: 54% vs control group: 42% OR = 1.83, CI = 1.23–2.73, P ≤ 0.01.

    Techniques: Control, Clarification Assay, Biomarker Discovery